Agenda & Speakers

Our three-day agenda is your gateway to discovering ground-breaking research, and technological advances. Join us and hear from passionate advocates and opinion leaders from across the pharmaceutical manufacturing industry.

Agenda

Keynote speakers

A man with a bald head, glasses, and a beard smiling, wearing a light blue collared shirt, standing against a plain light-colored wall.
A middle-aged woman with blonde hair, wearing a dark blazer over a white blouse, standing in an office or technology workspace with computers and monitors in the background.

Paul Forsyth

Consultant Pharmacist in Cardiology. NHS Golden Jubilee

Paul is Consultant Pharmacist in Cardiology, with his time split between NHS Golden Jubilee (80%) and NHS Greater Glasgow & Clyde (20%). His main academic interests are heart failure, coronary heart disease, primary prevention of cardiovascular disease, population health, and pharmacist advanced practice. He has authored >60 peer-reviewed publications and two textbook chapters. He has also been part of successful research grants from public, charity, and pharmaceutical company funders.

Professor Liz Bacon

Principal and Vice-Chancellor of Abertay University

Professor Liz Bacon FRSE, CEng, CSci, CITP, FBCS, FIScT is Principal and Vice-Chancellor of Abertay University and a Professor of Computer Science with a PhD in Artificial Intelligence. She is a Fellow of the Royal Society of Edinburgh, a National Teaching Fellow, and a Principal Fellow of the Higher Education Academy. She is a past President of BCS, The Chartered Institute for IT, and EQANIE (European Quality Assurance Network for Informatics Education), a past Trustee and Director of Bletchley Park Trust, and a past Chair of CPHC (Council of Professors and Heads of Computing) Committee, and in 2015 was voted the 35th Most Influential Woman in UK IT. Professor Bacon is a worldwide speaker on a range of topics such as the fourth industrial revolution and improving diversity and participation in STEM, particularly among women and people from disadvantaged backgrounds.

A man with gray hair wearing a white shirt and a purple tie with a circular pattern, standing in front of green foliage with a few butterflies.

Ian Rees

Assessor, Medicines and Healthcare products Regulatory Agency (MHRA)

Ian joined the MHRA as a GMP inspector in 2001, before this he was an inspector with the Veterinary Medicines Directorate and before that he helped create a startup biopharmaceutical firm during which time it was authorised by US FDA and MHRA’s predecessor, the MCA.

In 2004, Ian became a manager responsible for the London based team of GMP inspectors, he was promoted to Expert GMP Inspector in 2006 and Unit Manager Inspectorate Strategy and Innovation in 2014 managing a team of Expert GXP Inspectors.

Between 2008 and 2015, Ian was MHRA’s representative on the EMA’s GMDP Inspectors Working Group and also chaired the EMA/HMA Joint Audit Programme, the programme that assures consistency of GMP inspections throughout Europe. Ian was also one of the MHRA’s representative at EU Blood Authority Meetings.

Ian was part of the team that created MHRA’s Innovation Office in 2013 to provide regulatory advice to organisations developing innovative processes or novel manufacturing processes. In 2014 Ian was part of the team that created the UK cross regulatory ‘One Stop Shop’ to provide regulatory advice on ATMPs. Based on enquiries received by MHRA, Ian led MHRA’s work in developing the new regulatory framework for decentralised manufacture. Although he retired from MHRA in March 2023 he has since rejoined MHRA on a part-time basis to help complete the development of this new regulatory framework. On January 23rd 2025 the legislation (SI 2025 87) was signed into UK law and guidance documents were published on 10 June ahead of the legislation coming into effect 23rd July 2025.